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Indiana University-Purdue University Indianapolis, Indianapolis, IndianaABSTRACT Omega-3 polyunsaturated fatty acids (n-3 PUFA), enriched in fish oils, are increasingly recognized to have poten-
tial benefits for treating many human afflictions. Despite the importance of PUFA, their molecular mechanism of action remains
unclear. One emerging hypothesis is that phospholipids containing n-3 PUFA acyl chains modify the structure and composition
of membrane rafts, thus affecting cell signaling. In this study the two major n-3 PUFA found in fish oils, eicosapentaenoic (EPA)
and docosahexaenoic (DHA) acids, are compared. Using solid-state 2H NMR spectroscopy we explored the molecular organi-
zation of 1-[2H31]palmitoyl-2-eicosapentaenoylphosphatidylcholine (PEPC-d31) and 1-[
2H31]palmitoyl-2-docosahexaenoylphos-
phatidylcholine (PDPC-d31) in mixtures with sphingomyelin (SM) and cholesterol (chol). Our results indicate that whereas both
PEPC-d31 and PDPC-d31 can accumulate into SM-rich/chol-rich raftlike domains, the tendency for DHA to incorporate into rafts
is more than twice as great as for EPA. We propose that DHA may be the more bioactive component of fish oil that serves to
disrupt lipid raft domain organization. This mechanism represents an evolution in the view of how PUFA remodel membrane
architecture.INTRODUCTIONFish oil supplements are increasingly recognized in clinical
studies to have utility in treating a variety of important
human afflictions (1–4). However, the molecular mode
of action of fish oil remains unclear. The major bio-
active components of fish oil are the long-chain u-3 polyun-
saturated fatty acids (n-3 PUFA) eicosapentaenoic
(EPA, 20:5D5,8,11,14,17) and docosahexaenoic (DHA,
22:6D4,7,10,13,16,19) acids. Omega-3 fatty acids are character-
ized by having their last double-bond three carbons from the
terminal methyl (n or u) end of the chain. One emerging
mechanism of action for n-3 PUFA is modification of
membrane organization in response to uptake of EPA
and/or DHA into phospholipids of the cellular plasma
membrane (5–7).
It is now generally accepted that lipids are not randomly
distributed within a membrane. They are laterally arranged
in patches or domains of specific composition that provide
the environment necessary for the function of resident
proteins (8). Differential lipid-lipid and lipid-protein affinity
drives the formation of the domains. The best-known
example is the lipid raft (9,10). Lipid rafts are liquid-ordered
(lo) domains enriched in saturated sphingolipids and choles-
terol (chol) that serve as the platform for characteristic
signaling proteins. The extended conformation adopted by
the saturated acyl chains of sphingolipids is compatible
with close proximity to the four rigid cycloalkane rings of
the sterol, while hydrogen bonding of the amide on theSubmitted November 9, 2011, and accepted for publication June 12, 2012.
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0006-3495/12/07/0228/10 $2.00sphingosine backbone of a sphingolipid molecule to the
hydroxyl of adjacent sphingolipid and chol molecules glues
the raft together (11). By contrast, the shallow energy barrier
to rotation about C-C bonds in the repeating ¼C-C-C¼ unit
in a PUFA chain produces a multitude of rapidly changing
conformations (12,13) that push chol away, as evinced by
reduced solubility (14) and binding coefficients (15)
measured for the sterol in polyunsaturated phospholipids.
We have hypothesized from work on model membranes
that poor affinity of chol for PUFA promotes formation of
membrane (nonraft) domains rich in PUFA-containing
phospholipids but poor in chol (16–19). According to our
hypothesis, highly disordered PUFA-rich domains coexist
in a sea of bulk lipid with highly ordered lipid rafts that
are enriched in sphingolipids and chol (6,20). A recent
refinement to this view, based on detergent extraction
(21,22) and microscopy studies of living cells (22,23), has
polyunsaturated phospholipids infiltrating rafts as well as
forming (nonraft) domains (7,24). In either case, the basic
model is that n-3 PUFA modulate membrane organization
to diminish intracellular or extracellular signaling events.
Mixtures of polyunsaturated phospholipids with sphingo-
myelin (SM) and chol are the model membrane system that
we have developed to investigate the sorting of lipids into
SM-rich/chol-rich raftlike domains and PUFA-rich/chol-
poor nonraft domains (6,20). DHA, the most unsaturated
fatty acid commonly found in nature (25), was the focus
of our earlier work. In a series of studies we employed
solid-state 2H NMR spectroscopy, together with a battery
of complementary biophysical techniques, to characterize
1-palmitoyl-2-docosahexaenoylphosphatidylethanolaminehttp://dx.doi.org/10.1016/j.bpj.2012.06.016
DHA versus EPA Segregation in Membranes 229(PDPE)/SM/chol (1:1:1 mol) membranes (16–18). The
NMR spectra established the presence of motionally distinct
DHA-rich/chol-poor (less-ordered) and SM-rich/chol-rich
(more-ordered) domains that are nanoscale in size. Here
we turn our attention to EPA, which is typically more abun-
dant than DHA in fish oil capsules (26) and differs in its
efficacy in treating certain ailments (27–29).
We specifically address whether EPA and DHA interact
differentially with SM and chol. Utilizing solid-state 2H
NMR, the molecular organization of 1-[2H31]palmitoyl-2-
eicosapentaenoylphosphatidylcholine (PEPC-d31), 1-[
2H31]
palmitoyl-2-docosahexaenoylphosphatidylcholine (PDPC-
d31) and, as a control, 1-[
2H31]palmitoyl-2-oleoylphosphati-
dylcholine (POPC-d31) were compared in mixtures with
SM (1:1 mol) and with SM and chol (1:1:1 mol). Fig. 1
depicts the molecular structure of the phospholipids and
sphingolipid studied. The 2H NMR data establish that the
two major bioactive components of fish oil do not exert
the same effect on membrane organization. EPA segregates
into PUFA-rich/chol-poor (nonraft) domains more than
DHA. Strikingly, contrary to our earlier model, our experi-
ments reveal that a substantial amount of the DHA-contain-
ing phospholipid incorporates into SM-rich/chol-rich (raft)
domains. The observation that n-3 PUFA can infiltrate raft-
like domains in a lipid mixture is consistent with recent
studies in vitro and in vivo showing n-3 PUFA can incorpo-
rate into detergent-resistant membranes (DRM) (7).MATERIALS AND METHODS
Solid-state 2H NMR of model membranes
Materials
Avanti Polar Lipids (Alabaster, AL) was the source for POPC-d31, PEPC-
d31, PDPC-d31, and egg SM as either a stock item or custom synthesis.
Chol was purchased from Sigma Chemical (St. Louis, MO). All lipidsFIGURE 1 Molecular structure of PEPC, PDPC, POPC, and SM.were used without further purification. Deuterium-depleted water was ob-
tained from Cambridge Isotope Laboratories (Andover, MA).
Sample preparation
Lipids mixtures containing ~50 mg total lipid were codissolved in chloro-
form in molar ratio 1:1 and 1:1:1, respectively, for deuterated PC/SM and
deuterated PC/SM/chol samples (concentrations that will be assumed
henceforth unless otherwise specified). The chloroform was evaporated
under a steady stream of argon, and the samples were placed in vacuum
overnight to remove any remaining solvent. After adding 50 wt % degassed
50 mM Tris buffer to the dried lipids, the samples were vortex-mixed and
pH was adjusted to 7.5 in the presence of additional water. Three lyophili-
zations with deuterium-depleted water were then performed to remove trace
amounts of natural abundance 2HHO, and finally the lipids were hydrated at
50 wt %. In each instance, hydration was performed above 45C, which
exceeds the gel-to-liquid-crystalline temperature for SM that has the high-
est chain-melting temperature (39C) (30), to ensure proper mixing.
Samples were packed and sealed in 5-mm glass NMR tubes, stored
at80C and equilibrated at room temperature before experiments. Precau-
tions were taken throughout the procedure to minimize oxidation (16),
including limiting exposure to light and using a glove box purged with
argon during manipulations.
Spectroscopy
Solid-state 2H NMR spectra were acquired on a home-built spectrometer
(31) operating at 46.0 MHz with a 7.05 T super-conducting magnet (Oxford
Instruments, Osney Mead, UK). Pulse programming was accomplished
with an in-house assembled programmable pulse generator, while signals
were obtained in quadrature using a dual-channel digital oscilloscope
(R1200 M; Rapid Systems, Seattle, WA). Sample temperature was
regulated to 50.5C by a temperature controller (1600 Series; Love
Controls, Michigan City, IN). To eliminate spectral distortion due to
receiver recovery time, a phase-alternated quadrupolar echo sequence
(90x-t-90y-acquire-delay)n was implemented (32). Parameters were 90
pulse width z3 ms; separation between pulses t ¼ 50 ms; delay between
pulse sequences ¼ 1.0 s (gel phase) or 1.5 s (liquid-crystalline phase);
sweep width ¼ 5250 kHz (gel phase) or 5100 kHz (liquid-crystalline
phase); dataset ¼ 2 K; and number of transients ¼ 2048 (gel phase) or
1536 (liquid-crystalline phase).
Spectral analysis
First moments M1 were calculated from
2H-NMR spectra according to
M1 ¼
ZN
N
jujf ðuÞdu
ZN
N
f ðuÞdu
; (1)
where u is the frequency with respect to the central Larmor frequency and
f(u) is the lineshape (33). In practice, the integral was a summation over the
digitized data. The expression
M1 ¼ pﬃﬃﬃ
3
p

e2qQ
h

jSCDj (2)
was employed in the lamellar liquid-crystalline phase to relate the first
moment M1 to the average order parameter SCD for the perdeuterated
palmitoyl sn-1 chain via the static quadrupolar coupling constant
(e2qQ/h) ¼ 167 kHz. A reproducibility of 52% typically applies to the
M1 values measured.Biophysical Journal 103(2) 228–237
230 Williams et al.Spectra were also fast-Fourier-transform (FFT) dePaked to enhance
resolution in the liquid-crystalline phase (34). This numerical procedure
generates a spectrum representative of a planar membrane of single
alignment from the powder pattern signal. In processing the intrinsically
noisy dePaked data, the out-of-phase channel was zeroed before Fourier
transformation. The resultant spectra were reflected about the central
frequency and possess an improvement in signal/noise by a factor of
ﬃﬃﬃ
2
p
.RESULTS
Solid-state 2H NMR of model membranes
Solid-state 2H NMR spectra were obtained for 50 wt %
aqueous multilamellar suspensions of PEPC-d31, PDPC-
d31, and POPC-d31 in mixtures with SM, and with SM and
chol. The perdeuterated palmitoyl (16:0) sn-1 chain of the
PC molecules constitutes an essentially noninvasive probe
and the spectra compared the molecular organization of
EPA-containing PC versus DHA-containing PC in the
mixed membranes. Oleic acid (OA)-containing PC acted
as a monounsaturated control. The experiments were con-
ducted from high-to-low temperature over a range from 40
to 32C that encompasses the gel-to-liquid-crystalline
phase transition for each lipid. Representative spectra can
be seen in Fig. 2.
PC/SM mixtures
At low temperature, 24C, the spectra for PEPC-d31,
PDPC-d31, and POPC-d31 in the mixtures with SM are
symptomatic of the gel phase (Fig. 2, a–c). They appear
broad and relatively featureless with edges at563 kHz re-
flecting the slow rotational diffusion of the all-trans palmitic
acid chain that renders the lineshape nonaxially symmetric
(asymmetry parameter h s 0) (33). By contrast at high
temperature, 37C, the lineshape in each case is character-
istic of phospholipids in the lamellar liquid-crystalline
phase (Fig. 2, d–f). A superposition of powder patterns
from all of the individual deuterated positions along the per-
deuterated palmitoyl sn-1 chain produces a spectrum with
well-defined edges at 5~12 kHz corresponding to the
plateau region of nearly constant order in the upper portion
of the chain and a series of pairs of peaks within the spec-
trum associated with less-ordered methylenes and the
terminal methyl in the lower portion of the chain (33).
Greater disorder and a shorter plateau region are indicated
for the PUFA-containing phospholipids by the slightly nar-
rower width and lower intensity of the edges seen for PEPC-
d31 (Fig. 2 d) and PDPC-d31 (Fig. 2 e) relative to POPC-d31
(Fig. 2 f).
The spectra presented in Fig. 2 illustrate the tremendous
change in lineshape that accompanies the melting of lipid
chains at the gel-to-liquid-crystalline phase transition. The
first moment (M1), defined in Eq. 1, offers a way to quantify
lineshape and provides a means to investigate phase
behavior when plotted as a function of temperature. Fig. 3
shows the dependence on temperature for the values of M1Biophysical Journal 103(2) 228–237calculated from the spectra collected for PEPC-d31,
PDPC-d31, and POPC-d31 in the mixtures with SM between
32 and 40C. An abrupt drop signifying the transition
from gel (M1 > 1.3  105 s1) to liquid-crystalline (M1 <
0.6  105 s1) state is seen with each mixture (Fig. 3 A).
The midpoint temperature (designated as the transition
temperature Tm) and width of this drop in value for the
moment are, respectively, 16 and 5C for PEPC-d31 and
14 and 6C for PDPC-d31, as opposed to 3 and 18C
for POPC-d31.
An appraisal of data obtained with the corresponding pure
PC membranes establishes that the transition observed in the
mixed membranes with SM is broadened but hardly shifted
in temperature, and that the broadening is much smaller
with polyunsaturated than monounsaturated phospholipid.
For PDPC-d31, Tm ¼ 12.7C (35), and for POPC-d31,
Tm¼6C (36), and in both cases the transition is relatively
narrow (2–3C in width). Although to the best of our knowl-
edge details of the phase behavior have not been published
for PEPC, differential scanning calorimetry measurements
on pure PC bilayers with stearic (18:0) acid at the sn-1 posi-
tion and a series of unsaturated fatty acids at the sn-2 posi-
tion indicate Tm is slightly lower (3–4
C) with EPA than
DHA (37).
The modest impact upon the temperature of the phase
transition seen here for PEPC-d31, PDPC-d31, and POPC-
d31 in the presence of SM indicates that the mixing of PC
and SM is inhomogeneous, which we attribute to segrega-
tion into PC-rich and SM-rich domains. A similar interpre-
tation has previously been applied to 2H NMR spectra
recorded for POPC/SM mixtures (11,38,39). Other studies
on PEPC/SM or PDPC/SM mixtures have not been pub-
lished. The appreciably smaller SM-associated effect on
the width of the phase transition for PEPC-d31 and PDPC-
d31 in relation to POPC-d31 (Fig. 3 A) we ascribe to
enhanced separation between the PUFA-containing phos-
pholipids and sphingolipid compared to the OA-containing
phospholipid and sphingolipid.
PC/SM/chol mixtures
In Fig. 2 (lower panel), spectra for PEPC-d31, PDPC-d31,
and POPC-d31 in mixtures with SM and chol are plotted.
All three systems exhibit a spectrum that is gel-like in
appearance at 24C (Fig. 2, g–i). There is a reduction in
intensity in the wings compared to the spectra collected
under identical conditions in the absence of chol (Fig. 2,
a–c). The implication is that the sterol disrupts the regular
packing of the chains of PEPC-d31, PDPC-d31, and POPC-
d31 in the mixed membranes in the gel state. The spectra
observed in the liquid-crystalline state at 37C reveal
a remarkable differential in the response of each PC to the
introduction of chol into the mixed PC/SM systems
(Fig. 2, j–l). A spectrum that is similar in shape to POPC-
d31/SM (Fig. 2 f), but appreciably broader with edges at
520 kHz, is seen with POPC-d31/SM/chol (Fig. 2 l). This
FIGURE 2 2H NMR spectra for 50 wt %
aqueous dispersions in 50 mM Tris buffer
(pH 7.5) of PEPC-d31/SM (1:1 mol) (a and d),
PDPC-d31/SM (1:1 mol) (b and e), and POPC-
d31/SM (1:1 mol) (c and f) (upper panel), and
PEPC-d31/SM/chol (1:1:1 mol) (g and j), PDPC-
d31/SM/chol (1:1:1 mol) (h and k), and POPC-
d31/SM/chol (1:1:1 mol) (i and l) (lower panel).
Spectra were recorded at 24 (upper row) and
37C (lower row). (Arrows, j) Signals assigned to
the terminal methyl group on PEPC-d31 in PC-rich
(inner-splitting) and SM-rich (outer-splitting)
domains (see Fig. S2).
DHA versus EPA Segregation in Membranes 231broadening reflects the restriction to chain motion caused by
the rigid steroid ring moiety.
The addition of chol to the mixtures containing PUFA
and SM elicits a more profound alteration in spectral shape.
In the spectrum for PEPC-d31/SM/chol (Fig. 2 j), a narrow
component with edges at 512 kHz closely resembling
that seen in the absence of sterol (Fig. 2 d) appears super-
posed upon a wider second spectral component with edges
at 523 kHz. The distinction is less dramatic in the case
of the system containing DHA where a second spectral
component is not discernible (Fig. 2 k). Instead, the
spectrum for PDPC-d31/SM/chol is smeared-out with less
sharply defined edges at 519 kHz and barely resolved
peaks, except for the central pair due to the terminal methyl
group. Interpretation of the spectra collected at 37C
in terms of the sorting of lipids into PC-rich and SM-rich
domains that is amplified when chol is present to different
extent by EPA and DHA will be given later in the
Discussion.Fig. 3 B shows the variation with temperature of the first
moment evaluated for PEPC-d31, PDPC-d31, and POPC-d31
in the mixtures with SM and chol. A clear distinction is
apparent in the effect that the sterol has on the phase
behavior of EPA- versus DHA- and OA-containing phos-
pholipid in the mixtures with SM. The value of M1 for
POPC-d31/SM/chol slowly decreases with increasing
temperature and a discontinuity is no longer observed. The
introduction of chol into the POPC-d31/SM membrane
broadens the phase transition for POPC-d31 beyond detec-
tion, indicating extensive mixing of chol and POPC-d31.
PDPC-d31 responds comparably. The moments that were
measured for PDPC-d31/SM/chol similarly decline gradu-
ally and without break as temperature rises. In dramatic
contrast, much less thorough mixing of chol with PEPC-
d31 is indicated in PEPC-d31/SM/chol. A sharp fall in first
moment (fromM1 ~ 1.4 105 to ~0.6 105 s1) still occurs,
but is somewhat reduced in magnitude and (with midpoint
~18C and width ~12C) less precipitous compared toBiophysical Journal 103(2) 228–237
FIGURE 3 Variation of the first moment M1 derived from
2H NMR
spectra as a function of temperature for PEPC-d31/SM (1:1 mol) (-),
PDPC-d31/SM (1:1 mol) (:), and POPC-d31/SM (1:1 mol) (B) in the
absence (A) and presence (B) of chol (1:1:1 mol).
232 Williams et al.PEPC-d31/SM (Fig. 3 A). Unlike not only POPC-d31, but
also PDPC-d31, adding chol does not totally obliterate the
phase transition for PEPC-d31 in the mixed membrane.
We surmise from the temperature variation of the spectra
seen here for PEPC-d31, PDPC-d31, and POPC-d31 in
1:1 mol mixtures with SM and in 1:1:1 mol mixtures with
SM and chol that the lipids incompletely mix to form
PC-rich and SM-rich domains. Notably, a lower affinity of
sterol for EPA than DHA and thereby a greater propensity
for DHA-containing PC than EPA-containing PC to incor-
porate into SM-rich/chol-rich raftlike domains are implied.
It should be noted that the two-domain model invoked does
not rule out more complex phase behavior.Detergent extraction of cells
To complement our experiments on model membranes, we
explored the incorporation of EPA and DHA into biological
membranes. Details of the methods are provided in the
Supporting Material. The uptake of EPA versus DHA, rela-
tive to a bovine serum albumin control, into DRM (raft)
and detergent-soluble membranes (DSM) (nonraft) fractionsBiophysical Journal 103(2) 228–237isolated from EL4 cells by detergent extraction is compared
in Fig. S1 in the Supporting Material. EPA constituted ~2%
(not statistically significant, p ¼ 0.05) and ~11% of the total
fatty acid, respectively, found in DRM (upper panel) and
DSM (lower panel) after treatment with EPA, whereas
DHA constituted ~6% and ~33% of the total fatty acid found
in DRM andDSM, respectively, after treatment with DHA. It
is important to note that elevated levels of docosapentaenoic
(DPA, 22:5n-3) acid, the elongation product of EPA (40),
were detected in DRM (~6%) and DSM (~23%) when the
cells were treated with EPA. The combined concentration
of EPAþDPA approximately matches the uptake measured
for DHA in each fraction (i.e., the total level of n-3 PUFA
is roughly the same after treatment with EPA and DHA).DISCUSSION
The n-3 PUFA found in fish oils alleviate the symptoms
associated with a multitude of inflammatory, autoimmune,
and metabolic diseases (1–4). The diversity of the health
benefits suggests an underlying general mechanism. We
(5–7), and other research groups (21,23,41), have hypothe-
sized that changes in molecular organization within the
plasma membrane due to the incorporation of n-3 PUFA
into phospholipids modulate the conformation, and thereby
the activity, of signaling proteins. The formation of highly
disordered domains that are enriched in DHA-containing
phospholipids but depleted in chol is a model that we devel-
oped based on studies on lipid bilayers (6,20). These nonraft
domains form because the rapidly varying conformers adop-
ted by PUFA are averse to near approach to the rigid steroid
moiety of the sterol. An alternative model in which, para-
doxically, PUFA-containing phospholipids invade and
disrupt the highly ordered environment existing within lipid
rafts that are enriched in predominantly saturated chain
sphingolipids and chol has recently been developed based
on in-vitro and in-vivo studies (7,24). Central to the formu-
lation of this model was the significant amount of DHA
detected in DRM isolated from cells treated with PUFA.
In this investigation, we employed solid-state 2H NMR to
compare the molecular organization of an EPA- and DHA-
containing phospholipid in mixtures with the lipid raft mole-
cules SM and chol. EPA, with 20 carbons and five double
bonds, and DHA, with 22 carbons and six double bonds,
are the n-3 PUFA present in fish oils. Our experiments on
model membranes demonstrate a significant difference in
the partitioning of EPA and DHA between raft and nonraft
domains, and reveal that n-3 PUFA can accumulate in raft-
like domains.Segregation into PC-rich (nonraft) and SM-rich
(raft) domains
We interpret the 2H NMR spectra for PEPC-d31, PDPC-d31
and POPC-d31 mixed with SM (Fig. 2, upper panel) in terms
DHA versus EPA Segregation in Membranes 233of segregation into PC-rich and SM-rich domains. The
precipitous drop in value of the first moment derived from
the spectra as a function of temperature that accompanies
chain melting indicates in each instance that the transition
from gel to liquid-crystalline state is broadened and only
minimally shifted in temperature due to the presence of SM
(Fig. 3 A). Inhomogeneous mixing of PC and SM is implied.
A marked differential in the response of EPA and DHA to
the addition of chol is revealed by the 2H NMR spectra for
PEPC-d31, PDPC-d31, and POPC-d31 in the mixtures with
SM and chol (Fig. 2, lower panel). Substantial exposure to
chol is inferred for PDPC-d31 from the absence of a discon-
tinuity in the temperature dependence of the moments
derived from spectra (Fig. 3 B). A phase transition from
gel to liquid-crystalline state for PDPC-d31 is no longer
discernible in PDPC-d31/SM/chol because chol disturbs
the packing and obstructs reorientation of the DHA-contain-
ing phospholipid in the gel and liquid-crystalline states,
respectively. This behavior resembles that observed with
POPC-d31 in our POPC-d31/SM/chol control (Fig. 3 B)
and POPC-d31/SM/chol mixtures of similar composition
(11,8,39). There is, on the contrary, still an abrupt drop in
the plot of moment against temperature for PEPC-d31 in
PEPC-d31/SM/chol (Fig. 3 B). Less interaction with the
sterol, so that a phase transition remains, is implied for the
EPA-containing phospholipid compared to its DHA-con-
taining counterpart when mixed with SM and chol.
Further insight is gleaned from the average order param-
eter SCD, the correspondence of which to bilayer thickness
underscores the physical significance (42), calculated via
Eq. 2 from the first moment M1 for spectra at 37
C (see
Table S1 in the Supporting Material). The values of SCD in
PC/SM mixtures where chol was absent are lower for
PEPC-d31 (SCD ¼ 0.100) and PDPC-d31 (SCD ¼ 0.122)
than POPC-d31 (SCD ¼ 0.137), confirming our qualitative
assessment of the spectra. They show, moreover, that
EPA-containing PC is more disordered than DHA-contain-
ing PC in combination with SM. Consistent with demixing
into PC-rich and SM-rich domains that produces a popula-
tion-weighted average value for SCD from the two domains,
comparison with previously published data on POPC-d31
(36) and PDPC-d31 (43) indicates there is only a small (little
more than experimental uncertainty) increase due to SM. No
data for PEPC-d31 were found in a search of the literature.
After the addition of chol to the PC/SM mixed
membranes, SCD is increased in every case. The increase
is greatest with POPC-d31 (DSCD ¼ 0.094) and, reflecting
the poor affinity chol has for highly disordered PUFA
(20), is more modest with PEPC-d31 (DSCD ¼ 0.056) and
PDPC-d31 (DSCD ¼ 0.070). Based on the hierarchy of the
changes in SCD measured, we infer that the sterol is pushed
out of PC-rich domains into SM-rich domains by EPA >
DHA > OA. Here it is assumed that a given concentration
of chol exerts an equivalent ordering effect upon PEPC-d31,
PDPC-d31, and POPC-d31 individually. This assumption issupported by spectra published for [2H35]stearoyl-2-oleoyl-
phosphatidylcholine (SOPC-d35) (44) and [
2H35]stearoyl-2-
docosahexaenoylphosphatidylcholine (SDPC-d35) (45) and
by spectral moments reported for POPC-d31 (46) and
[2H31]palmitoyl-2-arachidonoylphosphatidylcholine
(PAPC-d31) (47) that suggest the sn-1 chain in the monoun-
saturated and polyunsaturated systems responds comparably
to chol.Domain size is increased with PUFA
The variation in appearance of the spectra for PEPC-d31/
SM/chol, PDPC-d31/SM/chol, and POPC-d31/SM/chol at
37C (Fig. 2, lower panel) implies that the size of domains
is enlarged by EPA and DHAwith respect to OA. That only
a single spectral component was observed in the spectrum
for POPC-d31/SM/chol (Fig. 2 l), we ascribe to incomplete
demixing into PC-rich (less-ordered) and SM-rich (more-
ordered) domains between which there is fast exchange
(48). A time-averaged spectrum, rather than a superposition
of spectral components, is produced because POPC-d31
moves among domains at a rate that exceeds the difference
in splitting for spectra from the two domains. Invoking the
difference in splitting (Dn ¼ 1600 Hz) previously reported
for the terminal methyl groups on POPC-d31 and [
2H31]-
N-palmitoylsphingomyelin (PSM-d31) in a PC/SM/chol
(3:3:2 mol) mixture of similar composition (38) as represen-
tative of PC-rich and SM-rich domains, the lifetime for the
residency of lipid molecules in a domain must be less than
t ¼ (2pDn)1 ¼ 9.9  105 s. The exchange of lipids
between domains is presumed to be mediated by lateral
diffusion with D ~ 5  1012 m2 s1 (49) so that the root-
mean displacement r¼ (4Dt)1/2 associated with the lifetime
places an upper limit of<45 nm upon the radius of domains.
Slow exchange at a rate less than the difference in split-
ting for spectra due to PEPC-d31 in PC-rich and SM-rich
domains, in contrast, applies to PEPC-d31/SM/chol (Fig. 2
j). The result is observation of a superposition of individual
spectral components from the two domains. There is a
narrow spectral component with edges at 512 kHz (less-
ordered PC-rich/chol-poor domains) superposed upon a
wider second component with edges at 523 kHz (more-
ordered SM-rich/chol-rich domains). The difference in
splitting (Dn ¼ 2800 Hz) for the terminal methyl groups
on PEPC-d31 in the two domains (highlighted by arrows
and see Fig. S2) then, by an analogous calculation to that
outlined above, corresponds to a lifetime for residency
in a domain that must exceed t ¼ 5.7  105 s and places
a lower limit of >35 nm on the size.
A second spectral component is not discernible in the
spectrum for PDPC-d31/SM/chol (Fig. 2 k). Instead, a broad-
ened spectrum in which individual peaks are smeared
out was observed. We attribute this blurring of spectral
features to exchange between domains on an intermediate
timescale that is comparable to the difference in splittingBiophysical Journal 103(2) 228–237
FIGURE 4 2H NMR spectra for PEPC-d31/SM/chol (1:1:1 mol) (a),
PDPC-d31/SM/chol (1:1:1 mol) (b), and POPC-d31/SM/chol (1:1:1 mol)
(c) at 30C. Standard FFT (powder pattern) spectra are plotted (left
column); FFT dePaked (aligned) spectra are also plotted (right column).
Peaks from signals assigned to the terminal methyl group on PEPC-d31
(a) and PDPC-d31 (b) in PC-rich (inner splitting) and SM-rich (outer split-
ting) domains are designated (arrows), whereas there is only a single peak
for the terminal methyl group on POPC-d31 (c) (see Fig. S3 and Fig. S4).
(Insets) Blow-up of these peaks (dashed lines are a Lorentzian fit). The
signals are symmetric in frequency about the center of the spectra and
only the peaks to the right of center with positive frequency are labeled.
234 Williams et al.for PDPC-d31 in PC-rich and SM-rich domains. A domain
size that falls between the ballpark estimates determined
based on the extremes for fast and slow exchange in the
OA- and EPA-containing systems is the likely explanation.
Thus, we deduce that domains are larger with EPA and
DHA relative to OA in PC/SM/chol-mixed membranes.
The effect is also more marked for EPA than DHA. We
emphasize that the splitting for the terminal methyl group
employed in our calculations is sensitive to exchange on
the timescale of the residual quadrupolar coupling associ-
ated with a rapidly rotating methyl group and that the
estimates for domain size constitute upper or lower limits.
A PUFA-induced increase in the size of domains was
not evident in our earlier work comparing PDPE with
POPE (17,18). 2H NMR spectra recorded for 1-[2H31]
palmitoyl-2-oleoylphosphatidylethanolamine (POPE-d31),
1-[2H31]palmitoyl-2-docosahexaenoylphosphatidylethanol-
amine (PDPE-d31) and PSM-d31 in PE/SM (1:1 mol) and
PE/SM/chol (1:1:1 mol) mixtures were consistent with the
DHA-containing phospholipid, as well as the OA-contain-
ing phospholipid, undergoing fast exchange between
PE-rich and SM-rich domains. The spectra for not only
POPE-d31, but also PDPE-d31, remained well resolved
upon the addition of chol. There was neither a smearing-
out of spectral features nor the appearance of a second spec-
tral component. An upper limit of <20 nm, moreover, was
placed upon domain size (18). That, unlike PDPC-rich
domains, an increase in size is not implied for PDPE-rich
domains in the presence of the sterol we attribute to head-
group structure. The smaller PE headgroup and hydrogen-
bonding to adjacent polar groups produce negative stress
curvature that drives a tendency to adopt inverted hexagonal
HII phase that is enhanced with increasing level of unsatura-
tion (50). Liquid-crystalline PDPE becomes inverted hexag-
onal at ~13C and is lamellar over only a very narrow
temperature range (6–10C). This inherent instability of
the PDPE bilayer may serve to restrict the area of PDPE-
rich domains relative to PDPC-rich domains.PUFA infiltrate rafts
An estimate of the amount of EPA- and DHA-containing
phospholipids that incorporates into SM-rich/chol-rich raft-
like domains can be made from the spectra for PEPC-d31/
SM/chol and PDPC-d31/SM/chol at 30
C displayed in
Fig. 4. The spectrum for PEPC-d31/SM/chol (Fig. 4 a, left)
closely resembles the spectrum at 37C (Fig. 2 j). It is
a superposition of narrow and broad components that, as
at the higher temperature, we attribute to PEPC-d31 in PC-
rich and SM-rich domains, respectively. However, the
spectra for PDPC-d31/SM/chol at 30 (Fig. 4 b, left) and
37C (Fig. 2 k) differ. A pair of peaks (indicated by arrows
and see Fig. S3) that coalesces into a single peak on going
up in temperature is visible in the spectrum acquired at
the lower temperature. We assign them to the terminalBiophysical Journal 103(2) 228–237methyl groups of PDPC-d31 in less-ordered PC-rich
(inner-peak) and more-ordered SM-rich (outer-peak)
domains. A reduction in the rate of exchange between
domains due to slower diffusion with decreased temperature
may be responsible. The observation of a separate NMR
signal from each domain for PEPC-d31 in PEPC-d31/SM/
chol and for PDPC-d31 in PDPC-d31/SM/chol means that
the relative concentration of PUFA-containing phospho-
lipids in the two domains can be evaluated. A similar calcu-
lation for POPC-d31 in POPC-d31/SM/chol was precluded.
The spectrum at 30C (Fig. 4 c, left and see Fig. S3) was
of the same form as at 37C (Fig. 2 l) and, consistent with
fast exchange between domains remaining at lower temper-
ature, a second spectral component did not appear.
We applied the FFT-dePaking algorithm (34) to deter-
mine the ratio of the quantity of PEPC-d31 and PDPC-d31
in PC-rich and SM-rich domains. By this numerical proce-
dure, spectra characteristic of a membrane of single align-
ment were obtained. Fig. 4 (and see Fig. S4) illustrates
that the powder patterns producing the two methyl peaks
in the conventional spectra for PEPC-d31/SM/chol (Fig. 4
a, left) become resolved as a pair of doublets (identified
by arrows) in the dePaked spectra (Fig. 4 a, right). The ratio
of the integrated intensity of inner and outer peaks, corre-
sponding to the ratio of the amount of PEPC-d31 in the
less-ordered PC-rich and more-ordered SM-rich domains,
was then estimated to be 3:2 assuming a Lorentzian fit
that is shown in the inset. Most of the EPA-containing PC
DHA versus EPA Segregation in Membranes 235forms a more-disordered domain, whereas a smaller fraction
(40%) incorporates into the SM-rich domain. By contrast,
a ratio of 1:3 for the integrated intensity of the inner and
outer peaks was determined when the pair of overlapping
doublets (identified by arrows, and also see Fig. S4) in the
dePaked spectrum for PDPC-d31/SM/chol (Fig. 4 b, right)
was analyzed. Although a more-disordered DHA-rich
domain is formed, the majority (75%) of the DHA-contain-
ing PC is found to infiltrate into the more-ordered SM-rich
(raftlike) domain. This remarkable finding is contrary to the
propensity to segregate into DHA-rich/chol-poor (nonraft)
domains identified in our previously published experiments
on PDPE/SM/chol mixtures (16–18).
It should be understood that our estimate for the relative
amount of PUFA-containing PC in each domain is approxi-
mate. The complexity of spectra meant that an analysis of
the entire lineshape, which would be ideal, was not feasible.
Instead, we focused upon the comparatively well-resolved
signals attributed to terminal methyl groups. A potential
problem with this approach is the possibility that a methy-
lene group, rather than the terminal methyl group in a
more-ordered domain, is responsible for the second inner-
most doublet in the dePaked spectrum for either PEPC-
d31/SM/chol (Fig. 4 a) or PDPC-d31/SM/chol (Fig. 4 b).
This possibility is discounted because a substantially greater
differential in spitting with respect to the innermost doublet
would be expected for a methylene group in the lower
portion of a chain where order rapidly decreases toward
the terminal methyl end.
The appearance of a minor spectral artifact at twice the
frequency of the true signal after application of the FFT
dePaking procedure (34) is another potential problem. A
pair of small satellite peaks either side of the innermost
doublet is an example of the artifact (Fig. 4 c) that, depen-
dent upon the disposition of signals, can affect the analysis
made here. The dePaked spectrum for PEPC-d31/SM/chol
(Fig. 4 a) is a worst case. There the artifact associated
with the innermost doublet that we attribute to the terminal
methyl group on PEPC-d31 in a less-ordered PC-rich domain
lies buried underneath the second innermost doublet that we
assign to the terminal methyl group on PEPC-d31 in a more-
ordered SM-rich domain. A slight overestimation of PEPC-
d31 found in the raftlike domain results. The situation is less
severe with the dePaked spectrum for PDPC-d31/SM/chol
(Fig. 4 b). In this case, the artifact accompanying the inner-
most doublet assigned to PDPC-d31 in a less-ordered
PC-rich domain falls just outside the second innermost
doublet attributed to PDPC-d31 in a more-ordered SM-rich
domain and is too small to be discerned.
How PDPE-d31 distributes between PE-rich and SM-rich
domains in a PDPE-d31/SM/chol (1:1:1 mol) membrane
could not be quantified in our earlier NMR work because,
as discussed above, only a single component spectrum
was observed (17). Preferential segregation of PDPE-d31
into PE-rich/chol-poor domains was inferred from the rela-tively small increase in average order parameter registered
by PDPE-d31 when chol was added to the PDPE-d31/SM
1:1 mol mixture. In support of this interpretation, detergent
extraction experiments conducted on PDPE/SM/chol (1:1:1
mol) showed that <30% PDPE was present in DRM where
>90% SM and chol was found (17). A reduction in the
amount of DHA-containing phospholipid that incorporates
into SM-rich/chol-rich domains is implied, therefore, for
PDPE compared to PDPC. The reduced affinity that PE
has for chol compared to PC offers an explanation for this
difference (14,15). We speculate that the uptake of DHA
into lipid rafts within biological membranes may be depen-
dent upon the lipid species into which the PUFA
incorporates.
Because our 2H-NMR experiments demonstrate that
PDPC incorporates into SM/chol-rich (raft) domains to
a greater extent than PEPC, we tested whether there is
a difference in the incorporation of EPA and DHA in cells.
DRM (rafts) and DSM (nonrafts) were isolated from EL4
cells in the presence of cold Triton X-100. It is acknowl-
edged that the detergent produces artifacts (51). Neverthe-
less, this widely used method is a valuable screen with
accepted utility as a predictive tool (10,52). Fig. S1
compares the uptake of EPA versus DHA, relative to a
bovine serum albumin control, into EL4 cells. The data
substantiate n-3 PUFA can be taken up into the DRM
(raft) (see Fig. S1, top panel) as well as the DSM (nonraft)
(see Fig. S1, bottom panel) fraction of a biological
membrane. Indeed, ~30% of the uptake of EPA or DHA
into EL4 cells was seen to be into DRM in earlier work
(22). The complexity of cellular metabolism should be
borne in mind here, because significant changes were de-
tected in the levels of other fatty acids. Although the amount
of DHA substantially exceeds the amount of EPA measured
in both fractions, preferential incorporation of DHA cannot
be inferred because the lower level of EPA comes at the
expense of conversion to its elongation product DPA (40).Biological implications
The data presented here agree with several cell culture and
animal studies that show n-3 PUFA can directly infiltrate
DRM, potentially impacting downstream cell signaling
(21–23,41,53). In whole animals, we and others have estab-
lished by a combination of imaging and lipidomic methods
that n-3 PUFA disrupt lipid raft clustering in EL4 and
primary B and T cells (21,23,53). By showing that DHA
incorporates into raftlike domains more than EPA, the
results obtained on model membranes in this work advance
the field by providing evidence that DHAwill be more effec-
tive than EPA in modifying lipid raft organization. This
observation is highly consistent with our recent studies in
which treatment of EL4 cells with DHA, but not EPA,
was found to perturb the clustering and size of cholera-toxin
induced lipid raft clusters (21).Biophysical Journal 103(2) 228–237
236 Williams et al.Considerable controversy remains on how n-3 PUFA
affect the spatial organization of lipid rafts. A primary issue
is whether n-3 PUFA disrupt lipid rafts or make them more
ordered. On the one hand, Kim et al. (23) proposed that n-3
PUFA can make raft domains more ordered. Using general-
ized polarization microscopy, these investigators reported
that synapse lipid rafts of CD4þ T cells from fat-1 trans-
genic mice, which have high endogenous levels of n-3
PUFA, demonstrate increased order. Zech et al. (41), on
the other hand, found that n-3 PUFA treatment of Jurkat
T cells significantly disrupted raft organization as deter-
mined with lipidomics and polarization imaging. The differ-
ence between systems (in vitro versus ex vivo) was offered
as an explanation (54).
Our work has the potential to explain the apparent
discrepancy at a molecular level. The differential in segrega-
tion between raft and nonraft domains revealed for EPA and
DHA suggest that the levels of these n-3 PUFA could deter-
mine impact on lipid raft organization. For instance, it is
possible that EPA-containing phospholipids upon forming
nonraft domains may redistribute chol molecules toward
rafts to make them more ordered within the synapse. In
contrast, DHA-containing phospholipids may make rafts
more disordered and could have the opposite effect on rafts
by forcing chol molecules out of rafts into nonraft regions.
Clearly, more data are needed on the model membrane
and cellular systems to establish a complete understanding
of how EPA and DHA serve to modify membrane domain
organization.SUPPORTING MATERIAL
Additional experimental methods, one table, four figures, and reference
(55) are available at http://www.biophysj.org/biophysj/supplemental/
S0006-3495(12)00672-8.
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